← Back to patent-cliff list
CAS 671204-00-5
(S)-2-benzyl-4-((3aR,7aS)-octahydro-2H-isoindol-2-yl)-4-oxobutanoic acid
Codes: MITI-007
Application context (from source-drug indications)
Type 2 diabetesMitiglinideDiabetesMitiglinide
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Mitiglinide | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
diethyl succinate→(bromomethyl)benzene→diethyl 2-benzylsuccinate→2-benzylsuccinic acid→(S)-2-benzylsuccinic acid→(3aR,7aS)-octahydro-1H-isoindole→(S)-2-benzyl-4-((3aR,7aS)-octahydro-2H-isoindol-2-yl)-4-oxobutanoic acid
diethyl succinate→(3aR,7aS)-octahydro-1H-isoindole→(S)-2-benzyl-4-((3aR,7aS)-octahydro-2H-isoindol-2-yl)-4-oxobutanoic acid→benzaldehyde→(Z)-3-(methoxycarbonyl)-4-phenylbut-3-enoic acid→(Z)-2-benzylidenesuccinic acid→(Z)-3-benzylidenedihydrofuran-2,5-dione→2-((Z)-benzylidene)-4-((3aR,7aS)-octahydro-2H-isoindol-2-yl)-4-oxobutanoic acid→(R)-1-phenylethan-1-amine
(3aR,7aS)-octahydro-1H-isoindole→(S)-2-benzyl-4-((3aR,7aS)-octahydro-2H-isoindol-2-yl)-4-oxobutanoic acid→3-phenylpropanoic acid→(R)-4-benzyloxazolidin-2-one→(R)-4-benzyl-3-(3-phenylpropanoyl)oxazolidin-2-one→tert-butyl 2-bromoacetate→tert-butyl (S)-3-benzyl-4-((R)-4-benzyl-2-oxooxazolidin-3-yl)-4-oxobutanoate→(S)-3-benzyl-4-((R)-4-benzyl-2-oxooxazolidin-3-yl)-4-oxobutanoic acid→(S)-2-benzyl-1-((R)-4-benzyl-2-oxooxazolidin-3-yl)-4-((3aR,7aS)-octahydro-2H-isoindol-2-yl)butane-1,4-dione
(3aR,7aS)-octahydro-1H-isoindole→(S)-2-benzyl-4-((3aR,7aS)-octahydro-2H-isoindol-2-yl)-4-oxobutanoic acid→tert-butyl 2-bromoacetate→(3aS,6R)-8,8-dimethylhexahydro-3H-3a,6-methanobenzo[c]isothiazole 2,2-dioxide→3-phenylpropanoyl chloride→1-((3aS,6R)-8,8-dimethyl-2,2-dioxidotetrahydro-3H-3a,6-methanobenzo[c]isothiazol-1(4H)-yl)-3-phenylpropan-1-one→tert-butyl (3S)-3-benzyl-4-((3aS,6R)-8,8-dimethyl-2,2-dioxidotetrahydro-3H-3a,6-methanobenzo[c]isothiazol-1(4H)-yl)-4-oxobutanoate→(3S)-3-benzyl-4-((3aS,6R)-8,8-dimethyl-2,2-dioxidotetrahydro-3H-3a,6-methanobenzo[c]isothiazol-1(4H)-yl)-4-oxobutanoic acid→(2S)-2-benzyl-1-((3aS,6R)-8,8-dimethyl-2,2-dioxidotetrahydro-3H-3a,6-methanobenzo[c]isothiazol-1(4H)-yl)-4-((3aR,7aS)-octahydro-2H-isoindol-2-yl)butane-1,4-dione
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.